These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2974346)

  • 21. Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI).
    Naccari F; Salpietro DC; De Sarro A; Masaracchio A; Barberi I
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):187-92. PubMed ID: 9583092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
    Iravani A
    Am J Med; 1993 Mar; 94(3A):89S-96S. PubMed ID: 8452189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New prospects in the treatment of urinary tract infections with modified-release ciprofloxacin].
    Trinchieri A
    Arch Ital Urol Androl; 2006 Sep; 78(3 Suppl 1):1-8. PubMed ID: 17469403
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
    Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ciprofloxacin in the treatment of respiratory infections].
    Poggi F; Tognazzi F; Doddi M; Lauri A; Placidi C
    Clin Ter; 1990 Jul; 134(2):111-7. PubMed ID: 2147611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
    Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Microbiological evaluation of ciprofloxacin efficacy for treatment of urinary tract infections].
    Kalisz J; Denys A; Szczerba W; Rusinek A; Rogowska-Kalisz A
    Med Dosw Mikrobiol; 1996; 48(3-4):169-75. PubMed ID: 9182138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciprofloxacin-induced severe cutaneous reaction and haemolysis in a young adult.
    Kundu AK
    J Assoc Physicians India; 2000 Jun; 48(6):649-50. PubMed ID: 11273551
    [No Abstract]   [Full Text] [Related]  

  • 31. Ciprofloxacin in the treatment of complicated urinary tract infections.
    Naber K; Sörgel F
    Chemioterapia; 1987 Jun; 6(2 Suppl):522-3. PubMed ID: 3509488
    [No Abstract]   [Full Text] [Related]  

  • 32. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid resolution of symptoms with ciprofloxacin therapy in 3859 hospitalised patients with urinary tract infection.
    Naber KG; Landen H
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S35-40. PubMed ID: 15037327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections.
    Cox CE
    Am J Med; 1989 Nov; 87(5A):157S-159S. PubMed ID: 2686415
    [No Abstract]   [Full Text] [Related]  

  • 36. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
    Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
    J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ciprofloxacin in the treatment of respiratory infections. Analysis of an Italian series].
    Maggiolo F; Bianchi W; Ohnmeiss H
    G Ital Chemioter; 1988; 35(1-3):39-44. PubMed ID: 3256511
    [No Abstract]   [Full Text] [Related]  

  • 39. Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice.
    Abbas AM; Chandra V; Dongaonkar PP; Goel PK; Kacker P; Patel NA; Shrivastava OP; Thakkar B; Tillotson GS
    J Chemother; 1989 Jul; 1(4 Suppl):858-9. PubMed ID: 16312672
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of oral ciprofloxacin on fecal bacteria in elderly patients.
    Höffler U; Grünig F; Brehmer B
    J Chemother; 1989 Jul; 1(4 Suppl):617-8. PubMed ID: 16312558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.